These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 11684630

  • 1. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD.
    Circulation; 2001 Oct 30; 104(18):2194-9. PubMed ID: 11684630
    [Abstract] [Full Text] [Related]

  • 2. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 30; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE, Parker JD.
    Circulation; 1996 Aug 01; 94(3):353-8. PubMed ID: 8759076
    [Abstract] [Full Text] [Related]

  • 4. Differing beta-blocking effects of carvedilol and metoprolol.
    Stoschitzky K, Koshucharova G, Zweiker R, Maier R, Watzinger N, Fruhwald FM, Klein W.
    Eur J Heart Fail; 2001 Jun 01; 3(3):343-9. PubMed ID: 11378006
    [Abstract] [Full Text] [Related]

  • 5. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR, Verberne HJ, Kok WE, van den Bogaard B, Schaap MC, Nieuwland R, Meijers JC, Somsen GA, Bakx A, Kamphuisen PW.
    J Nucl Med; 2013 Oct 27; 54(10):1733-9. PubMed ID: 23970363
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
    Vittorio TJ, Zolty R, Kasper ME, Khandwalla RM, Hirsh DS, Tseng CH, Jorde UP, Ahuja K.
    J Cardiovasc Pharmacol Ther; 2008 Mar 27; 13(1):51-7. PubMed ID: 18287590
    [Abstract] [Full Text] [Related]

  • 8. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA, Poornima I, Parikh P, Magovern M, Shen YT, Shannon RP.
    J Am Coll Cardiol; 2006 May 02; 47(9):1871-81. PubMed ID: 16682315
    [Abstract] [Full Text] [Related]

  • 9. β-blockade restores muscle sympathetic rhythmicity in human heart failure.
    Kubo T, Azevedo ER, Newton GE, Picton P, Parker JD, Floras JS.
    Circ J; 2011 May 02; 75(6):1400-8. PubMed ID: 21519151
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816
    [Abstract] [Full Text] [Related]

  • 11. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.
    Pharmacotherapy; 2009 Aug 26; 29(8):883-90. PubMed ID: 19637941
    [Abstract] [Full Text] [Related]

  • 12. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR.
    Circulation; 1996 Dec 01; 94(11):2817-25. PubMed ID: 8941107
    [Abstract] [Full Text] [Related]

  • 13. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
    Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, Di Lenarda A, Komajda M, Remme WJ, Lutiger B, Scherhag A, Lukas MA, Charlesworth A, Poole-Wilson PA.
    Eur Heart J; 2005 Nov 01; 26(21):2259-68. PubMed ID: 16040619
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of intravenous carvedilol versus metoprolol on baroreflex-mediated sympathetic circulatory regulation in rats.
    Yamamoto H, Kawada T, Shimizu S, Hayama Y, Shishido T, Iwanaga Y, Fukuda K, Miyazaki S, Sugimachi M.
    Int J Cardiol; 2019 Jun 15; 285():65-71. PubMed ID: 30876665
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.
    J Am Coll Cardiol; 1999 Nov 01; 34(5):1522-8. PubMed ID: 10551702
    [Abstract] [Full Text] [Related]

  • 16. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T, Azevedo ER, Newton GE, Parker JD, Floras JS.
    J Am Coll Cardiol; 2001 Nov 01; 38(5):1463-9. PubMed ID: 11691524
    [Abstract] [Full Text] [Related]

  • 17. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
    Bristow MR, Feldman AM, Adams KF, Goldstein S.
    J Card Fail; 2003 Dec 01; 9(6):444-53. PubMed ID: 14966783
    [Abstract] [Full Text] [Related]

  • 18. Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
    Metra M, Nodari S, Boldi E, Dei Cas L.
    Curr Cardiol Rep; 2000 May 01; 2(3):252-7. PubMed ID: 10980900
    [Abstract] [Full Text] [Related]

  • 19. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    J Card Fail; 2003 Dec 01; 9(6):464-8. PubMed ID: 14966787
    [Abstract] [Full Text] [Related]

  • 20. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun 01; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.